79 related articles for article (PubMed ID: 14587303)
61. Does response of RAS blockade on serum K+ levels influence its glycemic-mitigating response when combined with hydrochlorothiazide?
Deedwania PC; Zappe DH; Egan BM; Purkayastha D; Samuel R; Sowers JR
J Clin Hypertens (Greenwich); 2012 Jul; 14(7):415-21. PubMed ID: 22747613
[TBL] [Abstract][Full Text] [Related]
62. Ambulatory 24-hour cardiac oxygen consumption and blood pressure-heart rate variability: effects of nebivolol and valsartan alone and in combination.
Izzo JL; Khan SU; Saleem O; Osmond PJ
J Am Soc Hypertens; 2015 Jul; 9(7):526-35. PubMed ID: 26116459
[TBL] [Abstract][Full Text] [Related]
63. Estimating the gains of early detection of hypertension over the marginal patient.
Rodríguez-Lesmes P
PLoS One; 2021; 16(7):e0254260. PubMed ID: 34242312
[TBL] [Abstract][Full Text] [Related]
64. Valsartan/hydrochlorothiazide: a review of its use in the management of hypertension.
Wagstaff AJ
Drugs; 2006; 66(14):1881-901. PubMed ID: 17040120
[TBL] [Abstract][Full Text] [Related]
65. Combination therapy with valsartan/hydrochlorothiazide at doses up to 320/25 mg improves blood pressure levels in patients with hypertension inadequately controlled by valsartan 320 mg monotherapy.
Tuomilehto J; Tykarski A; Baumgart P; Reimund B; Le Breton S; Ferber P
Blood Press Suppl; 2008 Jun; 1():15-23. PubMed ID: 18705531
[TBL] [Abstract][Full Text] [Related]
66. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults.
Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A
Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047
[TBL] [Abstract][Full Text] [Related]
67. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
[TBL] [Abstract][Full Text] [Related]
68. Effects of force-titrated valsartan/hydrochlorothiazide versus amlodipine/hydrochlorothiazide on ambulatory blood pressure in patients with stage 2 hypertension: the EVALUATE study.
Lacourcière Y; Wright JT; Samuel R; Zappe D; Purkayastha D; Black HR;
Blood Press Monit; 2009 Jun; 14(3):112-20. PubMed ID: 19384192
[TBL] [Abstract][Full Text] [Related]
69. Triple combination therapy with amlodipine, valsartan, and hydrochlorothiazide vs dual combination therapy with amlodipine and hydrochlorothiazide for stage 2 hypertensive patients.
Destro M; Crikelair N; Yen J; Glazer R
Vasc Health Risk Manag; 2010 Sep; 6():821-7. PubMed ID: 20859551
[TBL] [Abstract][Full Text] [Related]
70. Pulse pressure responses in patients treated with Valsartan and hydrochlorothiazide combination therapy.
Carretta R; Trenkwalder P; Martinez F; Tykarski A; Teitelbaum I; Fagan T; Oddou P; Mallion J
J Int Med Res; 2003; 31(5):370-7. PubMed ID: 14587303
[TBL] [Abstract][Full Text] [Related]
71. Efficacy and effectiveness of valsartan/amlodipine and valsartan/amlodipine/hydrochlorothiazide in hypertension: randomized controlled versus observational studies.
Sison J; Vega RMR; Dayi H; Bader G; Brunel P
Curr Med Res Opin; 2018 Mar; 34(3):501-515. PubMed ID: 29210288
[TBL] [Abstract][Full Text] [Related]
72.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
73.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
74.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
75.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
76.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
77.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
78.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
79.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
